Inactive Instrument
Acticor Biotech SAS Stock Euronext Paris
Stocks
ALACT
FR0014005OJ5
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Avenard
CEO | Chief Executive Officer | - | 26/11/2013 |
Francois Guillet
DFI | Director of Finance/CFO | 68 | 13/10/2024 |
Anouar Sari
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Avenard
BRD | Director/Board Member | - | 26/11/2013 |
Catherine Boule
BRD | Director/Board Member | - | - |
Alain Parthoens
BRD | Director/Board Member | 66 | 24/10/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 12.69M | |
| -2.25% | +1.55% | +50.84% | +70.04% | 55.01B | |
| -1.32% | -2.71% | +34.27% | +77.57% | 54.24B | |
| +1.49% | +0.13% | -18.03% | -13.94% | 23.38B | |
| -0.57% | -4.13% | +2.34% | +387.73% | 22.57B | |
| +2.07% | +1.24% | +17.02% | -10.84% | 20.19B | |
| 0.00% | +3.00% | +27.41% | -29.52% | 17.86B | |
| -5.17% | -6.92% | +22.07% | +536.93% | 15.5B | |
| -6.69% | -5.11% | +169.13% | +304.89% | 14.2B | |
| +1.25% | +0.69% | +27.30% | +184.69% | 14.2B | |
| Average | -1.15% | -0.66% | +36.93% | +167.51% | 26.35B | |
| Weighted average by Cap. | -1.24% | -0.52% | +34.79% | +130.78% |
Employees
31
